Petushkova E V, Agafonov M O, Pron'ko G M
Biokhimiia. 1989 Sep;54(9):1485-9.
The effect of an affinity modifier of myosin ATPase representing a mixed anhydride of AMP and mesitylene carboxylic acid (AMP-MA) on myosin with protected active centers was studied. The protection of active centers was performed by the method of Wells et al. Which consists in the stabilization of the myosin-MgADP complex in the enzyme active center by way of cross-linking of the active center with a Co-phenanthroline complex simultaneously interacting with two SH-groups of the protein. Myosin with protected active center completely loses its ability to hydrolyze ATP; however, it can be reactivated by way of SH-group reduction with a subsequent MgADP release from the active centers. Treatment of myosin with protected active centers with AMP-MA does not result in the reduction of the enzyme activity after removal of the Co-phenanthroline complex. This suggests that the irreversible inhibition of myosin ATPase by AMP-MA occurs due to the protein modification outside the active center(s), which provides support for our earlier made conclusion concerning the existence of an additional (with respect to active centers) substrate-binding site in the myosin molecule.
研究了一种肌球蛋白ATP酶亲和修饰剂(一种AMP与均三甲苯羧酸的混合酸酐,即AMP-MA)对具有受保护活性中心的肌球蛋白的影响。活性中心的保护采用了韦尔斯等人的方法。该方法是通过活性中心与同时与蛋白质的两个SH基团相互作用的钴菲咯啉配合物交联,从而稳定酶活性中心中的肌球蛋白-MgADP复合物。具有受保护活性中心的肌球蛋白完全丧失了水解ATP的能力;然而,它可以通过还原SH基团并随后从活性中心释放MgADP的方式重新激活。用AMP-MA处理具有受保护活性中心的肌球蛋白,在去除钴菲咯啉配合物后,酶活性并未降低。这表明AMP-MA对肌球蛋白ATP酶的不可逆抑制是由于活性中心之外的蛋白质修饰引起的,这为我们先前关于肌球蛋白分子中存在一个(相对于活性中心而言)额外的底物结合位点的结论提供了支持。